CD45 and CD148 are transmembrane tyrosine phosphatases that regulate antigen-receptor signaling and thus strongly influence the sensitivity of the mammalian immune response. They potentiate signal transduction by dephosphorylating the C-terminal tail of the Src-family kinases, which releases autoinhibitory interactions and allows kinase activation. High levels of these phosphatases, however, attenuate signaling. The molecular mechanisms by which CD45 and CD148 are regulated are unclear. There is evidence that CD45 is inhibited by dimerization, but some studies suggest that an inactive pseudophosphatase domain, present in CD45 but not in CD148, may interfere with dimer formation. Using the purified cytoplasmic domains of CD45 and CD148 localized to artificial membranes, I will examine whether dimerization inhibits phosphatase activity. I will investigate how the pseudophosphatase domain contributes to CD45 function by testing whether it blocks dimerization, tethers substrates, or serves as an allosteric modulator upon phosphorylation. Finally, I will examine the possibility that there are direct interactions between CD45 and CD148 in cells by determining whether they heterodimerize on the cell surface. Understanding the regulatory mechanisms of the phosphatases that control the activation and proliferation of hematopoietic cells will be important for understanding the sensitivity and control mechanisms of the immune response. Public Health Relevance: The tyrosine phosphatase proteins CD45 and CD148 are found at high levels in the cells of the immune system and are important for controlling the sensitivity of the immune response. Mutations in CD45 have been proposed to be associated with several autoimmune diseases in humans and mice, including lupus, Graves disease, autoimmune lymphoproliferation, and multiple sclerosis. CD148 suppresses cell growth and cancer in several cell types, but its function in the cells of the immune system is not yet clear. Understanding the regulation of these signaling proteins will help us better understand the balance of signals necessary for maintaining appropriate growth patterns and sensitivity in immune cells

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI082926-01
Application #
7676561
Study Section
Special Emphasis Panel (ZRG1-F07-E (20))
Program Officer
Prograis, Lawrence J
Project Start
2009-09-30
Project End
2011-09-29
Budget Start
2009-09-30
Budget End
2010-09-29
Support Year
1
Fiscal Year
2009
Total Cost
$50,054
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Freedman, Tanya S; Tan, Ying X; Skrzypczynska, Katarzyna M et al. (2015) LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. Elife 4: